Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Overseas India B.V., a promoter of Procter and Gamble Health Limited, has filed a disclosure under SEBI Takeover Regulations 31(4). The filing confirms its shareholding of 8,601,071 shares, amounting to 51.82% of Procter and Gamble Health Limited's paid-up capital. Furthermore, it declares that none of these shares were encumbered (pledged) as of March 31, 2026. This disclosure represents a routine compliance update.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited declared a final dividend of Rs. 60 per equity share for the financial year 2025-26, pending shareholder approval at the upcoming Annual General Meeting. The company also issued detailed communication regarding the deduction of Tax at Source (TDS) on this dividend income. It outlines the applicable TDS rates for resident and non-resident shareholders and specifies the necessary documentation, such as PAN and Form 121, to ensure proper tax compliance.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the exchanges about disclosures received under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company received intimations from Temple Trees Impex and Investment Pvt Ltd (TTIPL) and Procter & Gamble Home Products Private Limited (PGHPPL), both entities belonging to its promoter group. This announcement signifies a routine regulatory filing indicating that promoter group companies have undertaken transactions in the company's shares, triggering reporting obligations under insider trading rules. Investors should monitor subsequent detailed filings (Annexure 1, if provided) to understand the nature and scale of these promoter group transactions.